Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Diagnosis of Sickle Cell Disease (SCD) and Other Rare Anemia Disorders (RADs) for Personalized Medicine

NCT07206095 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT07206095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Diagnosis of Sickle Cell Disease (SCD) and Other Rare Anemia Disorders (RADs) for Personalized Medicine
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Overall status
Recruiting
Start date
November 13, 2020
Completion date
May 31, 2028
Enrollment
200 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

anemia due to membrane defect, congenital dyserythropoietic anemia (cda), enzyme disorder; anemia, hemoglobin disorder, rare anemia disorders, sickle cell disease, spherocytosis, hereditary, stomatocytosis, thalassaemia